Digestive Enzymes
Natural health product licensed in Canada
- Licence holder
- FoodState Incorporated
- NPN or DIN-HM
- 80066458
- Status
- Active licence
- Licence date
- 18 January 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 75,000 Unités d'hémoglobine basées sur la tyrosine, du FCC | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Glucan 1,4-alpha-glucosidase | 40 Unités d'alpha-galactosidase du FCC | Not calculated |
| Pectin pectylhydrolase Source : Polygalacturonase | 50 Endo-PGU | Not calculated |
| Pectin pectylhydrolase Source : Polygalacturonase | 33.3 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : alpha-Galactosidase | 350 Unités d'alpha-galactosidase du FCC | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 468 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 11.7 mg | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : bêta-Glucanase | 17 FCC BGU | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : bêta-Glucanase | 4.9 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Hemicellulase | 1,290 FCC HCU | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Hemicellulase | 2.6 mg | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Phytase | 3.2 FCC FTU | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 10,000 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 20 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 2,000 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 13.3 mg | Not calculated |
| bêta-galactosidase Source : Lactase | 900 FCC ALU | Not calculated |
| Protéase Source : Protéase fongique | 15 FCC SAPU | Not calculated |
| bêta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 675 Unités de sumner du FCC | Not calculated |
| Protéase Source : Protéase fongique | 3,000 Unités d'hémoglobine basées sur la tyrosine, du FCC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 1,000 FCC BAU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 3.3 mg | Not calculated |
| Protéase bactérien Source : Protéase bactérien | 2,000 Unités de protéase bactérienne du FCC | Not calculated |
| Protéase bactérien Source : Protéase bactérien | 2.7 mg | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 40,000 Unités de papaïne du FCC | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 1.3 mg | Not calculated |
| Papaïne Source : Papain | 40,000 Unités de papaïne du FCC | Not calculated |
| Papaïne Source : Papain | 0.8 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 20,000 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 133.3 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 93.8 mg | Not calculated |
| bêta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 6.8 mg | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Glucan 1,4-alpha-glucosidase | 40 mg | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Phytase | 2.1 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : alpha-Galactosidase | 23.3 mg | Not calculated |
| bêta-galactosidase Source : Lactase | 9 mg | Not calculated |
| Protéase Source : Protéase fongique | 7.5 mg | Not calculated |
| Protéase Source : Protéase fongique | 6 mg | Not calculated |
Non-medicinal ingredients
Son de riz, Hypromellose, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Contains digestive enzymes. Digestive aid. Helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains). Helps digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If you have gastrointestinal lesions/ulcers, are taking anticoagulant agents or anti-inflammatory agents, or are having surgery, consult a health care practitioner prior to use. If you have allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach, and tomato), consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in such a case, discontinue use. Nausea, vomiting, and diarrhoea have been known to occur, in which case discontinue use (and consult a health care practitioner).
Source
Official Health Canada record, licence 80066458
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.